Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.6.5 is now displayed on the page, replacing the prior version. This indicates a minor, system-level update to the page rather than a substantive change to the study details or user-facing content.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now shows revision v3.6.4, reflecting a minor internal update to the ClinicalTrials.gov interface. No study data, eligibility criteria, or results content were changed.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.6.3 replaces v3.6.2 on the page, signaling a small update to the page's version history rather than a substantive change to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a minor update to the page metadata. This does not modify study content, eligibility criteria, or results.SummaryDifference0.0%

- Check69 days agoChange DetectedRecruitment status indicates the study is no longer enrolling participants. The page now includes new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a revision label (Revision: v3.6.0).SummaryDifference0.3%

- Check76 days agoChange DetectedThe page's revision label updated from v3.5.4 to v3.5.5, indicating a newer version of the study documentation has been published.SummaryDifference0.0%

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.